Salud Care

What Salud Care does

Salud Care India Limited is a privately held pharmaceutical contract manufacturer headquartered in Ahmedabad, India, with a manufacturing facility in Roorkee, Uttarakhand. Founded in 2003, the company produces finished pharmaceutical formulations across six dosage forms — tablets, capsules, liquids, ointments, dry powders, and nasal sprays — at a single integrated plant with daily capacity of 5 million tablets, 500,000 capsules, 100,000 bottles, and 200,000 ointment tubes. The portfolio spans more than 950 drug combinations, with a ready COPP dossier list covering over 220 combinations for international markets. Therapeutic strengths are concentrated in cardiovascular, anti-diabetic, and dermatology segments, and differentiated formulations include DCGI-approved Teneligliptin products, bi-layer Metformin + Glimeperide tablets, and tablet-in-capsule Rosuvastatin combinations. Manufacturing is supported by an in-house GLP-approved testing laboratory equipped with HPLC, stability chambers, microbiology, spectrophotometry, and dissolution analysis instrumentation.

The company holds PIC/s, WHO-GMP, ISO 9001, and FSSAI certifications, alongside country-specific GMP clearances from Nigeria (NAFDAC), Cambodia, Kenya (PPB), and the Philippines (cGMP), with Uganda NDA and Sri Lanka NMRA certifications pending. Two sub-brands extend the platform: Alvio Pharmaceuticals operates as the domestic ethical marketing arm with a 350+ person sales force reaching over 35,000 medical professionals across 17 Indian states, and Stelvio Healthcare targets global markets with nutraceutical and cosmeceutical products.

Salud Care generates revenue through three streams: contract and third-party manufacturing services for domestic and international pharmaceutical companies, domestic product sales via the Alvio Pharmaceuticals marketing arm, and direct exports to LATAM, Southeast Asia, CIS, Middle East, and African markets. The go-to-market model is B2B and enquiry-based, relying on a Partner With Us program, business development executives in Hyderabad, Mumbai, and Delhi, and direct international export relationships. The stated strategic objective is to scale global reach via distribution and marketing partnerships in semi-regulated markets.

Name

Salud Care

Legal name

Salud Care India Limited

Website

https://saludcare.co.in

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

101–250 employees

Short description

Salud Care India Limited is a PIC/s-certified pharmaceutical contract manufacturer headquartered in Ahmedabad, India, producing 950+ drug combinations across tablets, capsules, liquids, ointments, and nasal sprays for domestic and international pharma partners across 22 countries.

Ownership category

akta.pro rank

Headquarters

HQ city

Ahmedabad

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Contract Manufacturing Services: Provides third-party contract manufacturing of pharmaceutical formulations, nutraceutical formulations, and herbal formulations for domestic and international markets
2. Product Sales (Domestic): Sales through Alvio Pharmaceuticals marketing arm covering 17 states in India with 350+ sales representatives reaching 35,000+ medical professionals
3. International Export: Export of pharmaceutical products with COPP certification to regulated and semi-regulated markets across LATAM, SEA, CIS, Middle East, and Africa

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

Salud Care India Limited is a pharmaceutical contract manufacturer producing finished dosage formulations including tablets, capsules, liquids, ointments, dry powders, and nasal sprays at a PIC/s and WHO:GMP certified facility in Roorkee, Uttarakhand. The company manufactures over 950 drug combinations, with a ready COPP list of 220+ products for international markets, and operates through its Alvio Pharmaceuticals marketing arm (350+ sales staff across 17 Indian states) and Stelvio Healthcare brand for nutraceuticals and cosmeceuticals.

Product overview

Salud Care India Limited is a pharmaceutical contract manufacturing company established in 2003, offering a comprehensive portfolio of over 950 pharmaceutical formulations across multiple therapeutic segments. The company operates as a unified manufacturing services platform producing tablets, capsules, liquids, ointments, dry powders, and nasal sprays, with major strengths in Cardiovascular, Anti-Diabetic, and Dermatology product categories. Key products include Teneligliptin formulations (with DCGI approval), Bi-Layer Metformin Tablets, and Tablet in Capsule Technology for Rosuvastatin combinations. The company also operates two sub-brands: Stelvio Healthcare for nutraceuticals and cosmeceuticals, and Alvio Pharmaceuticals for domestic ethical marketing across 17 Indian states.

Differentiator

Problem solved

Functional benefit

Brands

• Stelvio Healthcare: Wellness and healthcare brand specializing in unique Nutraceuticals and Cosmeceutical products globally.
• Alvio Pharmaceuticals

Products and services

• Contract Manufacturing Services Third-party contract manufacturing of pharmaceutical, nutraceutical, and herbal formulations for domestic and international pharmaceutical companies, with PIC/s and WHO:GMP certified production of tablets, capsules, liquids, ointments, dry powder, and nasal sprays.
• Cardiovascular Pharmaceutical Formulations Cardiovascular pharmaceutical formulations including tablets and capsules for heart-related conditions, representing one of the company's major therapeutic strengths.
• Anti-Diabetic Pharmaceutical Formulations Anti-diabetic pharmaceutical formulations including Metformin, Glimepiride, Teneligliptin combinations, representing one of the company's major therapeutic strengths.
• Dermatology Pharmaceutical Formulations Dermatological pharmaceutical formulations including creams, ointments, gels, and lotions for skin conditions, representing one of the company's major therapeutic strengths.
• Stelvio Healthcare Nutraceuticals and Cosmeceuticals Subsidiary brand specializing in wellness and healthcare nutraceuticals and cosmeceutical products for global markets.
• Alvio Pharmaceuticals Ethical Marketing Ethical marketing division operating in 17 Indian states with a team of over 350 individuals reaching 35,000 medical professionals, distributing Salud Care's pharmaceutical products domestically.

Quantifiable outcome

• Over 950 drug combinations manufactured
• +4 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Alvio PharmaceuticalscoreChannel Partner/ Reseller/ DistributorEthical marketing arm of Salud Care. Marketing operations in 17 states in India with a team of over 350 individuals, reaching over 35,000 Medical Professionals. Fully owned/operated subsidiary handling domestic pharmaceutical marketing and distribution.
• Stelvio HealthcarecoreChannel Partner/ Reseller/ DistributorSpecialized wellness and healthcare brand focusing on unique Nutraceuticals and Cosmeceutical products globally. Sister company/brand of Salud Care for non-pharmaceutical healthcare products.
• Distribution and Marketing Partners (International)minorChannel Partner/ Reseller/ DistributorSalud Care actively seeks partners for distribution and marketing in LATAM, SEA, CIS, Middle East and African markets. Looking for partners to help expand therapeutic footprint currently covering 22 countries.
• Contract Manufacturing PartnerscoreStrategic or Co-development PartnerCompanies seeking to contract manufacture their pharmaceutical, nutraceutical, and herbal formulations at third parties. Salud Care provides PIC/s certified, WHO:GMP approved manufacturing services for these partners.

Scale indicators14 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Piramal Pharma Solutions: Piramal's CDMO arm offers contract manufacturing of finished dosage forms (tablets, capsules, liquids, ointments) across multiple therapeutic categories with global regulatory approvals. Highly comparable B2B CDMO model with emerging-market focus.
• Gland Pharma: India-based injectables-focused CDMO with strong international regulatory footprint (USFDA, EMA, etc.) and contract manufacturing heritage. Comparable as a pure-play Indian CDMO serving regulated and emerging markets.
• Neuland Laboratories: Indian CDMO specializing in APIs and finished dosage manufacturing with USFDA, EDQM, and WHO-GMP certifications. Closely comparable in scale, regulatory posture, and emerging-market focus.
• Strides Pharma: India-based pharmaceutical manufacturer with a portfolio of generic finished dosages and contract manufacturing services for regulated and emerging markets. Comparable in international regulatory focus and dosage-form breadth.
• Granules India: Indian pharmaceutical manufacturer focused on high-volume finished dosages (paracetamol, metformin, etc.) with substantial export footprint. Comparable in scale, vertical integration, and emerging-market reach.
• Akums Drugs & Pharmaceuticals: India's largest contract manufacturer of pharmaceutical formulations across tablets, capsules, liquids, ointments, and injectables. Closest peer in pure-play CDMO positioning with similar dosage-form breadth and domestic + export customer mix.

Broad incumbents

• Syngene International: Larger Indian CRDMO offering development and manufacturing services for small molecules and biologics. Broader scope (discovery through commercial manufacturing) but operates a comparable contract-services model for global pharma.
• Aurobindo Pharma: Major Indian generics manufacturer with substantial contract manufacturing and export operations across emerging markets. Broader portfolio including APIs and finished dosages; comparable export channel to LATAM, Africa, SEA.
• Cipla: One of India's largest pharma companies with extensive contract manufacturing, OTC, and branded generics operations across emerging markets (Africa, India, SEA). Much larger but comparable therapeutic overlap (respiratory, anti-diabetic, derma).

Emerging players

• Divis Laboratories: Indian API and intermediates manufacturer with growing finished-dosage CDMO services and global regulatory certifications. Comparable regulatory depth but more API-weighted than Salud's finished-dosage focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/Saludcare.official
• LinkedInlinkedin.com/company/salud-care

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Salud Care